ご挨拶（講師紹介）
代表取締役 三島 茂
これまで従事してきた、製薬（Pharmaceuticals）、資産運用（Asset Management）、投資調査（Investment Research）をつなげて、Pharma Asset Research （日本名：ファーマセット・リサーチ）を社名としました。2011年に証券アナリストを引退し、事業開発のお手伝いをさせていただく機会が多くなりました。2014年７月より株式会社として活動を続けています。
経歴
1977年に三共株式会社（現、第一三共株式会社）に入社し、医療用医薬品の営業（MR）、臨床開発、海外展開を担当した後、1988年より外資系金融機関の証券アナリスト。UBS証券会社、バークレイズ証券会社などセルサイドを経て、1999年よりCitibank、アライアンス・バーンスタイン株式会社にてファンド運用に従事。2012年フロンティア・マネジメント顧問を経て、2014年にファーマセット・リサーチを設立。
学歴
1977年 東京大学薬学部製薬化学科卒業
1983年 ミシガン大学経営大学院卒業（MBA）
Profile of the founder
Summary:
Shigeru Mishima joined Sankyo Co., Ltd. (now Daiichi Sankyo Company, Limited) in 1977, where he worked as a medical representative (MR) and was also involved in clinical development and overseas expansion.
In 1988, he began working as a securities analyst for foreign financial institutions. After serving as a sell-side analyst for UBS Securities Japan Ltd. and Barclays Bank PLC (now Barclays Capital Japan Limited), Mr. Mishima worked as a fund manager, first at Citibank Global Asset Management from 1999 and then at Alliance Capital Asset Management (Japan) Ltd. (now AllianceBernstein Japan Ltd.) from 2003. In 2009 he returned to UBS, where he worked as an analyst in the pharmaceuticals industry.
Academic Background:
University of Michigan (Ann Arbor), Graduate School of Business Administration (MBA, 1983)
University of Tokyo, Faculty of Pharmaceutical Sciences (B.Sc. 1977)
Experience:
At Sankyo Co., Ltd., Mr. Mishima served as a medical representative (MR) covering hospitals and clinics in the Tokyo area for four years, after which he was involved in the clinical development of injectable antibiotics as well as in the overseas development of the company’s best-selling cholesterol-lowering agent.
As a securities analyst, he was ranked second in the pharmaceutical sector by "Institutional Investor” for 1998-99. After subsequently moving to the buy-side i.e., asset management, he covered a wide range of companies in domestic and overseas consumer goods industries, including pharmaceuticals, other healthcare, foods, beverages, tobacco, cosmetics, toiletries, and toys. Upon returning to the sell-side in 2009, Mr. Mishima was involved in the IPO of Otsuka Holdings Co., Ltd.